MedTrace Logo

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

NCT03984071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2019-06-12

No results posted yet for this study

Summary

Estimated glomerular filtration rate(eGFR) is significantly reduced in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study is to research that the incidence of adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction is significantly higher when the glomerular filtration rate below a certain value.

Conditions

  • ST Elevation Myocardial Infarction

Sponsors & Collaborators

  • Dongying Zhang

    lead OTHER

Eligibility

Min Age
24 Years
Max Age
93 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2018-02-28
Completion
2018-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03984071 on ClinicalTrials.gov